PresentationGood morning, and welcome to the SELLAS Life Sciences R&D Day. As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the event. I'd now like to turn the call over to your host, Dr. Angelos Stergiou, President and Chief Executive Officer at SELLAS Life Sciences. Please go ahead, Angelos.Angelos StergiouFounder, President, CEO & Director Good morning, and welcome to SELLAS' R&D Day. Thank you all for joining us today. I wo ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the top long-term biotechnology stocks to buy. On October 27, SELLAS Life Sciences (NASDAQ:SLS) announced the immediate exercise of warrants for 22.4 million shares. The company raised $31 million in gross proceeds from the offering. Sellas Life Sciences Group Inc. (SLS) Advances Cancer Pipeline with $31M Funding and Upcoming R&D Showcase Investors who exercised the warrants, issued in March and August of last year, are poised to receive new register ...